Resources Blog What’s an Antibody and What’s Important About It?

What’s an Antibody and What’s Important About It?

Biointron 2024-01-20 Read time: 2 mins
antibody.jpg
Image credit: Encyclopædia Britannica

Antibodies, also known as immunoglobulins, are Y-shaped proteins that are produced by the immune system to recognize and neutralize foreign substances, such as viruses, bacteria, and toxins. They are an important part of the body's defense mechanism against infections and diseases. 

Antibodies are made up of two heavy chains and two light chains that are linked by disulfide bonds. The tips of the Y-shaped structure are called the antigen-binding sites, which are responsible for recognizing and binding to specific antigens on the surface of foreign substances. The rest of the antibody, known as the constant region, interacts with other immune cells to trigger the elimination of the foreign substance. 

Antibodies are generated by B cells, which are a type of white blood cell. B cells produce a diverse repertoire of antibodies through a process called somatic recombination, where segments of antibody genes are shuffled and combined to create unique antibody sequences. This allows the immune system to recognize a wide range of foreign substances. 

At Biointron, we specialize in antibody discovery and development. Our high-throughput single B cell screening platform can screen millions of plasma B cells from immunized animals to identify rare, antigen-specific antibodies. We also offer a rapid and reliable recombinant antibody production service, which can provide you with a purified, guaranteed amount of recombinant antibody in just two weeks. 

If you're interested in learning more about our antibody discovery and development services, please don’t hesitate to contact us. 

Subscribe to our Blog

Recent Blog

DOI:10.1038/s41557-024-01507-y Antibody–drug conjugates (ADCs) have emerged as a revolutionary class of targeted cancer therapies, combining the specificity of monoclonal antibodies with the potent cytotoxicity of small-molecule drugs. While traditional ADCs typ

Jun 14, 2024
Blog

Antibody Engineering & Therapeutics Europe 2024 was held in London, UK on 4-6 June, 2024. As Europe's leading antibody conference for accelerating next-generation antibodies to commercial success, topics discussed included:Emerging modalities: ADCs, degraders, and beyondFc

Jun 12, 2024
Blog

The BIO International Convention 2024 was held in San Diego, CA from June 3-6. It is the largest event for biotechnology with over 18,500 industry leaders in attendance, sharing the latest advancements in the industry. The most popular topics included:AI and Digital HealthNext Generation

Jun 10, 2024
Blog

10.1038/nbt1127. DOI:10.1038/nbt1127Antibody mimetics, also known as non-immunoglobulin scaffolds, are engineered proteins designed to mimic the antigen-binding properties of antibodies. Unlike traditional antibodies, which are based on the immunoglobulin structure, antibody mimetics are derived fro

Jun 07, 2024
Blog

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.